S4DX SIGNED
The world’s first “digital data-fingerprint” for human blood samples.
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0S4DX project word cloud
Explore the words cloud of the S4DX project. It provides you a very rough idea of what is the project "S4DX" about.
Project "S4DX" data sheet
The following table provides information about the project.
| Coordinator |
SMART4DIAGNOSTICS GMBH
Organization address contact info |
| Coordinator Country | Germany [DE] |
| Total cost | 1˙477˙250 € |
| EC max contribution | 1˙034˙075 € (70%) |
| Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
| Code Call | H2020-EIC-SMEInst-2018-2020-3 |
| Funding Scheme | SME-2b |
| Starting year | 2020 |
| Duration (year-month-day) | from 2020-04-01 to 2021-09-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | SMART4DIAGNOSTICS GMBH | DE (MUNICH) | coordinator | 1˙034˙075.00 |
Map
Project objective
'Smart4Diagnostics (S4DX) has developed the world’s first “digital human sample data-fingerprint” for human blood samples in pre-preanalytics. We aks for EIC-support to catapult this innovation into a market-changing product.
S4DX detects and reduces pre-preanalytical errors at sample collection when patients are still present. This is a quantum leap in quality and safety for patients, doctors and laboratories. They receive reliable results and painful re-visits and re-collection of samples are avoided. With our innovation we change medical diagnostics from 'trust-based” to “evidence-based”. We provide a complete dataset on the quality of each human sample from blood draw until analysis. Our solution provides the new pre-preanalytical data-standard for sensitive medical diagnostics in the future. S4DX “digital human sample fingerprint” will be the necessary data-baseline for highly sensitive tests (e.g. liquid biopsy). Market-entry in Europe with our MVP is planned for Dec. 2020. Our data will be used to refine our pattern-recognition algorithms and thus provide the basis for personalized and precision diagnostics.
We collaborate with leading international partners. Roche Diagnostics and Sarstedt are technical advisors, leading European lab chains (Bioscientia/Germany, Medisupport/Switzerland and Certe/ Netherlands) are implementation partners; Würth Electronics provides access to manufacturers and supply chain partners.
The company was founded in Jan. 2018, won the EIT-Health Wildcard as best eHealth start-up in Europe, the Hackathon of the TU Munich/Germany as best start-up and was chosen globally by the WHO as one of ten most promising start-ups in 2018. In April 2019 the Investment committee of the High-Tech-Gründerfonds voted unanimously to accept S4DX for further investment of 1 Mio. €, in July 2019 ACI/ Boston accepted us as one of six companies globally in the “Gold-Track-Program” for massive global scaling in healthcare. '
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "S4DX" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "S4DX" are provided by the European Opendata Portal: CORDIS opendata.